Comparing Smoking Treatment Programs for Lighter Smokers - 1
Completed
National Institute on Drug Abuse (NIDA)
Phase 2
2003-09-01
The purpose of this study was to compare two different types of Food and Drug Administration
(FDA) approved smoking cessation medications (nicotine patch or bupropion) used in
conjunction with two levels of counseling. It was hypothesized that the higher level of
counseling would have the highest rates of treatment completion and highest rates of
abstinence.
Comparing Smoking Treatment Programs for Lighter Smokers - 1
Completed
Peter Gariti
Phase 2
2003-09-01
The purpose of this study was to compare two different types of Food and Drug Administration
(FDA) approved smoking cessation medications (nicotine patch or bupropion) used in
conjunction with two levels of counseling. It was hypothesized that the higher level of
counseling would have the highest rates of treatment completion and highest rates of
abstinence.
Comparing Smoking Treatment Programs for Lighter Smokers - 1
Completed
University of Pennsylvania
Phase 2
2003-09-01
The purpose of this study was to compare two different types of Food and Drug Administration
(FDA) approved smoking cessation medications (nicotine patch or bupropion) used in
conjunction with two levels of counseling. It was hypothesized that the higher level of
counseling would have the highest rates of treatment completion and highest rates of
abstinence.
The study has two objectives/aims:
Aim 1: To test the efficacy of the intervention among adult smokers with cardiovascular
disease, pulmonary disease and diabetes mellitus related illnesses (later modified to Chinese
adults with and without diseases); and
Aim 2: To examine a set of measures (background, general health, psychosocial, and smoking
process) that are associated with smoking cessation at 6 and 12 months
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
